Multi-year, 1143-patient genetic study identified unique types of multiple myeloma
On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…
Biotechnology | Disease | Life Science History | NIH | Oncology | Radiology | Therapeutics | Women's Health
American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
FDA approved first cell-based gene therapy for adult patients with multiple myeloma
On Mar. 27, 2021, the FDA approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients…
FDA approved Bristol Myers Squibbﾒs and bluebird bioﾒs Abecma for Relapsed or Refractory Multiple Myeloma
On Mar. 26, 2021, Bristol Myers Squibb and bluebird bio announced that the FDA had approved Abecma (idecabtagene…
FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple Myeloma
On May 1, 2020, Janssen Pharma, a Johnson & Johnson company, announced the U.S. Food and Drug Administration…
Biotechnology | COVID-19 | FDA | Therapeutics
Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
Washington University School of Medicine gifted $20 million to boost multiple myeloma research
On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center performed its 5,000th bone marrow transplant
On Aug. 9, 2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…
National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studies
On Jun. 22, 2008, National Cancer Institute researchers announced that cells from a blood-borne cancer called multiple myeloma…
The FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma
On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…